Crossref
Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case
Journal of Oncology Research and Therapy · 12.09.2025 · 10 (3)
DOI: 10.29011/2574-710x.10304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology Research and Therapy, online erschienen am 12.09.2025. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2025). Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case. Journal of Oncology Research and Therapy, 10(3). https://doi.org/10.29011/2574-710x.10304
Vancouver
Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case. Journal of Oncology Research and Therapy. 2025;10(3). doi:10.29011/2574-710x.10304
BibTeX
@article{euvimed2025,
title = {Extended Treatment with Magnetic Nanoparticle Hyperthermia in a “First-in-Human” Trial Demonstrates Safety and Feasibility in an Advanced Cervical Cancer Case},
journal = {Journal of Oncology Research and Therapy},
year = {2025},
volume = {10},
number = {3},
doi = {10.29011/2574-710x.10304}
}
EUVIMED